Dianna M Milewicz Selected Research

Familial Thoracic 1 Aortic Aneurysm

2/2014	Successes and challenges of using whole exome sequencing to identify novel genes underlying an inherited predisposition for thoracic aortic aneurysms and acute aortic dissections.
9/2011	Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms.
6/2011	Recurrent chromosome 16p13.1 duplications are a risk factor for aortic dissections.
12/2010	Rare copy number variants disrupt genes regulating vascular smooth muscle cell adhesion and contractility in sporadic thoracic aortic aneurysms and dissections.
5/2010	Genetic testing in aortic aneurysm disease: PRO.
10/2008	Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms.
1/2008	Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction.
10/2007	MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II.
11/2006	Genetic basis of thoracic aortic aneurysms and dissections: potential relevance to abdominal aortic aneurysms.
11/2005	Genetic basis of thoracic aortic aneurysms and aortic dissections.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dianna M Milewicz Research Topics

Disease

35	Thoracic Aortic Aneurysm 01/2020 - 07/2003
21	Aneurysm (Aneurysms) 01/2022 - 11/2005
19	Aortic Diseases 12/2021 - 05/2009
15	Marfan Syndrome (Marfan's Syndrome) 01/2019 - 04/2003
14	Aortic Dissection 03/2022 - 11/2010
11	Familial Thoracic 1 Aortic Aneurysm 02/2014 - 07/2005
8	Inflammation (Inflammations) 01/2022 - 10/2007
7	Aortic Aneurysm (Aneurysm, Aortic) 01/2020 - 05/2009
6	Vascular Diseases (Vascular Disease) 11/2017 - 08/2006
5	Intracranial Aneurysm (Cerebral Aneurysm) 12/2016 - 07/2005
5	Genetic Predisposition to Disease (Genetic Predisposition) 09/2011 - 08/2003
4	Stroke (Strokes) 01/2022 - 05/2009
4	Thoracic Aorta Dissection 01/2018 - 01/2013
4	Abdominal Aortic Aneurysm 01/2018 - 09/2011
3	Vascular Remodeling 12/2020 - 09/2006
3	Rupture 01/2020 - 01/2014
3	Type IV Ehlers-Danlos Syndrome 11/2019 - 08/2006
3	Vascular System Injuries 01/2019 - 05/2012
3	Hyperplasia 01/2019 - 08/2013
3	Patent Ductus Arteriosus 10/2018 - 11/2006
3	Hypertension (High Blood Pressure) 10/2018 - 07/2005
2	Atherosclerotic Plaque (Atheroma) 01/2022 - 01/2021
2	Atherosclerosis 12/2020 - 01/2018
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020 - 11/2017
2	Fibrosis (Cirrhosis) 01/2019 - 01/2005
2	Neointima 01/2019 - 05/2010
2	Bicuspid Aortic Valve Disease 01/2018 - 01/2017
2	Hypertelorism 12/2016 - 08/2006
2	Coronary Artery Disease (Coronary Atherosclerosis) 08/2013 - 05/2009
2	Inborn Genetic Diseases (Disease, Hereditary) 09/2012 - 05/2010
2	Loeys-Dietz Syndrome 01/2008 - 08/2006
1	Disease Progression 01/2021
1	Bites and Stings (Sting) 01/2020
1	Ventricular Tachycardia 01/2020
1	Spontaneous Rupture 01/2019
1	Uterine Rupture 01/2019
1	Intestinal Perforation 01/2019
1	Pulmonary Arterial Hypertension 10/2018
1	Peripheral Arterial Disease 01/2018
1	Ascending Aorta Dissection 01/2018

Drug/Important Bio-Agent (IBA)

22	1,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA 01/2019 - 07/2003
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2012
7	Angiotensin IIIBA 01/2020 - 10/2007
6	Contractile ProteinsIBA 01/2022 - 11/2006
6	Transforming Growth Factor-beta Type II ReceptorIBA 12/2016 - 07/2005
5	Phosphotransferases (Kinase)IBA 01/2022 - 08/2013
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 07/2005
5	ElastinIBA 01/2019 - 09/2006
5	Protein Isoforms (Isoforms)IBA 01/2018 - 11/2010
5	Fibrillin-1IBA 01/2017 - 04/2003
4	Myosin-Light-Chain KinaseIBA 01/2019 - 11/2010
4	Losartan (Cozaar)FDA LinkGeneric 01/2019 - 09/2013
4	CollagenIBA 01/2019 - 09/2006
4	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2018 - 11/2006
4	Myosins (Myosin)IBA 01/2018 - 12/2010
4	Transforming Growth Factor beta (TGF-beta)IBA 01/2017 - 01/2005
3	Protein Kinases (Protein Kinase)IBA 01/2022 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
3	CholesterolIBA 01/2022 - 01/2020
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2020 - 09/2006
3	Transforming Growth Factor-beta Type I ReceptorIBA 01/2020 - 08/2006
3	Collagen Type III (Type III Collagen)IBA 11/2019 - 08/2006
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	LipidsIBA 12/2020 - 01/2019
2	InflammasomesIBA 01/2020 - 01/2017
2	Arginine (L-Arginine)FDA Link 10/2018 - 07/2005
2	Hormones (Hormone)IBA 12/2017 - 04/2016
2	ThrombospondinsIBA 01/2017 - 12/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2014 - 07/2013
2	Actins (F Actin)IBA 05/2009 - 12/2007
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2007 - 07/2005
2	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 08/2006 - 07/2005
1	Extracellular Matrix ProteinsIBA 01/2022
1	Thrombospondin 1IBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	Chaperonin Containing TCP-1IBA 12/2021
1	ChaperoninsIBA 12/2021
1	Protein Kinase CIBA 12/2020
1	oxidized low density lipoproteinIBA 12/2020
1	Oxidized LDL ReceptorsIBA 12/2020
1	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 12/2020
1	Scavenger Receptors (Scavenger Receptor)IBA 12/2020
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2020
1	InterferonsIBA 01/2020
1	Mitochondrial DNA (mtDNA)IBA 01/2020
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Irbesartan FDA LinkGeneric 01/2019
1	cobinamideIBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2019
1	Phosphatidic Acids (Phosphatidic Acid)IBA 01/2019
1	Captopril (Capoten)FDA LinkGeneric 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2018

Therapy/Procedure

7	Therapeutics 01/2021 - 08/2006
1	Genomic Medicine 03/2022
1	Ambulatory Care (Outpatient Care) 10/2018
1	Stents 01/2018
1	Endovascular Aneurysm Repair 01/2018